PPCB
Propanc Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · AU
$1.80
+5.26%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-200.6%
Return on equity
-147.6%
Return on assets
-183.5%
Return on invested capital
0.00x
Asset turnover
-$5.7M
Cash from operations
$0.81
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026